Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.

Front Med (Lausanne)

Department of General Surgery, The Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.

Published: February 2022

[This corrects the article DOI: 10.3389/fmed.2021.795427.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892580	PMC
http://dx.doi.org/10.3389/fmed.2022.862010	DOI Listing

Publication Analysis

corrigendum lncrna

lncrna msc-as1

msc-as1 diagnostic

diagnostic biomarker

biomarker predicts

predicts poor

poor prognosis

prognosis patients

patients gastric

gastric cancer

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!